ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
3,1,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
3,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Hypoglycaemic coma,Coma states,Neurological disorders NEC,Nerv,N
5,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
6,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
6,3,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
7,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
7,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8,2,Headache,Headaches NEC,Headaches,Nerv,N
8,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10,1,Neural tube defect,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
11,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
13,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
14,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
14,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
14,5,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
15,1,Device failure,Device issues NEC,Device issues,Prod,N
16,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
17,1,Headache,Headaches NEC,Headaches,Nerv,N
17,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
17,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
17,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
18,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
18,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
19,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
20,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
21,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
21,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
21,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
22,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
22,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
22,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
23,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
23,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
23,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
24,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
24,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
25,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,2,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
25,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
26,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
26,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
27,1,Hypoglycaemic unconsciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
28,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
29,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
29,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
29,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
30,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
30,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
30,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
30,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
30,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
30,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
30,7,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
30,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
31,1,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
32,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
32,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
32,3,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
33,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
33,2,Femoral pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
33,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
34,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
35,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
36,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
36,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
36,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
36,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
37,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
37,2,Euglycaemic diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
37,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
37,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
38,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
38,2,Headache,Headaches NEC,Headaches,Nerv,N
38,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
39,2,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
39,3,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
40,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,1,Headache,Headaches NEC,Headaches,Nerv,N
41,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
42,1,Hyperphosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
43,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
43,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,3,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
